https://www.selleckchem.com/pr....oducts/limertinib.ht
13; CI 1.06-1.24) compared to patients without diabetes. Inflammatory biomarkers including C-reactive protein (CRP), lactate dehydrogenase (LDH), and erythrocyte sedimentation rate (ESR) were increased in patients with diabetes compared to non-diabetic patients (P less then 0.05 for all the comparisons). In hospitalized patients with COVID-19, diabetes was correlated with increased disease severity and mortality.The recent years have been passed with significant progressions in the utilization of microfluidic technologies for cellula
Like
Comment
Share
